Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2017 Filed Feb 7, 2017 21:32 UTC |
Race GeoffEVP, CFO & CBO
|
SaleCommon Stock | 1,692 | $11.00 | $18,612.00 |
DisclosureSEC source: 0001209191-17-008360 · doc4.xml · nonDerivative · entry 2 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,198 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 21:31 UTC |
Luthringer RemyDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,185 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-17-008356 · doc4.xml · derivative · entry 7 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,719 Underlying: Common Stock · 2,185 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest as follows: 25% vested on December 4, 2016 and the remainder vests in quarterly installments over 3 years thereafter. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 21:31 UTC |
Luthringer RemyDirector · President & CEO
|
SaleCommon Stock | 2,185 | $11.00 | $24,035.00 |
DisclosureSEC source: 0001209191-17-008356 · doc4.xml · nonDerivative · entry 4 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 21:31 UTC |
Luthringer RemyDirector · President & CEO
|
Exercise / conversionCommon Stock | 2,185 | $4.71 | $10,291.35 |
DisclosureSEC source: 0001209191-17-008356 · doc4.xml · nonDerivative · entry 3 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:32 UTC |
Race GeoffEVP, CFO & CBO
|
SaleCommon Stock | 19,758 | $11.02 | $217,733.16 |
DisclosureSEC source: 0001209191-17-008360 · doc4.xml · nonDerivative · entry 1 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,890 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:31 UTC |
Luthringer RemyDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,096 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-17-008356 · doc4.xml · derivative · entry 6 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,904 Underlying: Common Stock · 32,096 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest as follows: 25% vested on December 4, 2016 and the remainder vests in quarterly installments over 3 years thereafter. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:31 UTC |
Luthringer RemyDirector · President & CEO
|
SaleCommon Stock | 32,096 | $11.02 | $353,697.92 |
DisclosureSEC source: 0001209191-17-008356 · doc4.xml · nonDerivative · entry 2 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:31 UTC |
Luthringer RemyDirector · President & CEO
|
Exercise / conversionCommon Stock | 32,096 | $4.71 | $151,172.16 |
DisclosureSEC source: 0001209191-17-008356 · doc4.xml · nonDerivative · entry 1 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:30 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-17-003672 · doc4.xml · derivative · entry 3 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 Underlying: Common Stock · 1,600 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option shall vest as follows: 25% vested December 14, 2016 and then in quarterly installments over 3 years thereafter. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:30 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
SaleCommon Stock | 1,600 | $12.03 | $19,248.00 |
DisclosureSEC source: 0001209191-17-003672 · doc4.xml · nonDerivative · entry 2 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:30 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,600 | $4.71 | $7,536.00 |
DisclosureSEC source: 0001209191-17-003672 · doc4.xml · nonDerivative · entry 1 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:28 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001209191-17-002652 · doc4.xml · derivative · entry 5 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,274 Underlying: Common Stock · 250 shares Expires 2025-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:28 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,250 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-17-002652 · doc4.xml · derivative · entry 4 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,750 Underlying: Common Stock · 17,250 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:28 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
SaleCommon Stock | 17,500 | $12.00 | $210,000.00 |
DisclosureSEC source: 0001209191-17-002652 · doc4.xml · nonDerivative · entry 3 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:28 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
Exercise / conversionCommon Stock | 250 | $5.19 | $1,297.50 |
DisclosureSEC source: 0001209191-17-002652 · doc4.xml · nonDerivative · entry 2 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:28 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
Exercise / conversionCommon Stock | 17,250 | $4.71 | $81,247.50 |
DisclosureSEC source: 0001209191-17-002652 · doc4.xml · nonDerivative · entry 1 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 16:39 UTC |
Davidson MichaelChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $11.75 | $0.00 |
DisclosureSEC source: 0001209191-17-002130 · doc4.xml · derivative · entry 1 Davidson Michael · CIK 0001691467 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable as to 25% on January 3, 2018; the balance of the shares underlying the option shall vest and become exercisable in 12 successive equal quarterly installments, in each case so long as the Reporting Person provides continuous service to the Issuer on each such date. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 21:41 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-16-157015 · doc4.xml · derivative · entry 3 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 12,000 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vested as to 25% of the shares on December 4, 2016 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 21:41 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
SaleCommon Stock | 17,000 | $12.51 | $212,670.00 |
DisclosureSEC source: 0001209191-16-157015 · doc4.xml · nonDerivative · entry 2 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 - $13.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 21:41 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 12,000 | $4.71 | $56,520.00 |
DisclosureSEC source: 0001209191-16-157015 · doc4.xml · nonDerivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 21:49 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0001209191-16-155671 · doc4.xml · derivative · entry 2 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-12-13 F3 · derivative.exercise_price: The exercise price is the closing price of the Issuer's common stock on December 14, 2016. F4 · derivative.exercise_date: This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 21:49 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155671 · doc4.xml · derivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F2 · derivative.expiration_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:02 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0001209191-16-155685 · doc4.xml · derivative · entry 2 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2026-12-13 F3 · derivative.exercise_price: The exercise price is the closing price of the Issuer's common stock on December 14, 2016. F4 · derivative.exercise_date: This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:02 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155685 · doc4.xml · derivative · entry 1 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F2 · derivative.expiration_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:04 UTC |
Race GeoffEVP, CFO & Chief Business Off.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0001209191-16-155688 · doc4.xml · derivative · entry 2 Race Geoff · CIK 0001610382 · EVP, CFO & Chief Business Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2026-12-13 F3 · derivative.exercise_price: The exercise price is the closing price of the Issuer's common stock on December 14, 2016. F4 · derivative.exercise_date: This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:04 UTC |
Race GeoffEVP, CFO & Chief Business Off.
|
GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155688 · doc4.xml · derivative · entry 1 Race Geoff · CIK 0001610382 · EVP, CFO & Chief Business Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F2 · derivative.expiration_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:06 UTC |
Luthringer RemyDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0001209191-16-155690 · doc4.xml · derivative · entry 2 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-12-13 F3 · derivative.exercise_price: The exercise price is the closing price of the Issuer's common stock on December 14, 2016. F4 · derivative.exercise_date: This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:06 UTC |
Luthringer RemyDirector · President & CEO
|
GrantRestricted Stock Unit · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155690 · doc4.xml · derivative · entry 1 Luthringer Remy · CIK 0001610384 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F2 · derivative.expiration_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:01 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0001209191-16-155681 · doc4.xml · derivative · entry 2 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-12-13 F3 · derivative.exercise_price: The exercise price is the closing price of the Issuer's common stock on December 14, 2016. F4 · derivative.exercise_date: This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 22:01 UTC |
Levine Mark S.SVP,General Counsel & Sec.
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155681 · doc4.xml · derivative · entry 1 Levine Mark S. · CIK 0001617236 · SVP,General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F2 · derivative.expiration_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 14:17 UTC |
Index Venture Associates III Ltd10% owner
Index Venture Associates IV Ltd10% owner
Index Venture Associates V Ltd10% owner
Yucca (Jersey) SLP10% owner
|
OtherWarrant Shares · Derivative | 202,634 | $0.00 Strike: $5.77 | $0.00 |
DisclosureSEC source: 0001140361-16-089635 · doc1.xml · derivative · entry 2 Index Venture Associates III Ltd · CIK 0001503683 · 10% owner Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner Index Venture Associates V Ltd · CIK 0001611751 · 10% owner Yucca (Jersey) SLP · CIK 0001591294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Shares · 202,634 shares Expires 2017-03-18 F4 · shares: Composed of 35,376 warrant shares exercised by Index Ventures III (Jersey), L.P., 71,862 warrant shares exercised by Index Ventures III (Delaware), L.P., 1,280 warrant shares exercised by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 warrant shares exercised by Index Ventures IV (Jersey), L.P., 4,631 warrant shares exercised by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 warrant shares exercised by Index Ventures V (Jersey), L.P., 313 warrant shares exercised by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 warrant shares exercised by Yucca (Jersey) SLP. F2 · derivative.underlying_shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP. F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P. F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act. F6 · ownership.nature: This Statement Form 4 is being filed jointly by the Index Entities. Each of the Index Entities disclaims beneficial ownership held of record by any of the other Index Entities, except to the extent of their respective proportionate pecuniary interest(s) therein. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 14:17 UTC |
Index Venture Associates III Ltd10% owner
Index Venture Associates IV Ltd10% owner
Index Venture Associates V Ltd10% owner
Yucca (Jersey) SLP10% owner
|
OtherCommon Stock | 202,634 | $5.77 | $1,169,603.45 |
DisclosureSEC source: 0001140361-16-089635 · doc1.xml · nonDerivative · entry 1 Index Venture Associates III Ltd · CIK 0001503683 · 10% owner Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner Index Venture Associates V Ltd · CIK 0001611751 · 10% owner Yucca (Jersey) SLP · CIK 0001591294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,690,906 F2 · shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP. F3 · balance_after: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P. F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act. F6 · ownership.nature: This Statement Form 4 is being filed jointly by the Index Entities. Each of the Index Entities disclaims beneficial ownership held of record by any of the other Index Entities, except to the extent of their respective proportionate pecuniary interest(s) therein. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 14:24 UTC |
Ollier MicheleDirector · 10% owner
|
OtherWarrant Shares · Derivative | 202,634 | $0.00 Strike: $5.77 | $0.00 |
DisclosureSEC source: 0001140361-16-089642 · doc1.xml · derivative · entry 2 Ollier Michele · CIK 0001503685 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Shares · 202,634 shares Expires 2017-03-18 F4 · shares: Composed of 35,376 warrant shares exercised by Index Ventures III (Jersey), L.P., 71,862 warrant shares exercised by Index Ventures III (Delaware), L.P., 1,280 warrant shares exercised by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 warrant shares exercised by Index Ventures IV (Jersey), L.P., 4,631 warrant shares exercised by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 warrant shares exercised by Index Ventures V (Jersey), L.P., 313 warrant shares exercised by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 warrant shares exercised by Yucca (Jersey) SLP. F2 · derivative.underlying_shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP. F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey)L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P. F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 14:24 UTC |
Ollier MicheleDirector · 10% owner
|
OtherCommon Stock | 202,634 | $5.77 | $1,169,603.45 |
DisclosureSEC source: 0001140361-16-089642 · doc1.xml · nonDerivative · entry 1 Ollier Michele · CIK 0001503685 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,690,906 F2 · shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP. F3 · balance_after: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey)L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P. F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 19:22 UTC |
De Rubertis FrancescoDirector · 10% owner
|
OtherWarrant Shares · Derivative | 202,634 | $0.00 Strike: $5.77 | $0.00 |
DisclosureSEC source: 0001140361-16-089639 · doc1.xml · derivative · entry 2 De Rubertis Francesco · CIK 0001601521 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Shares · 202,634 shares Expires 2017-03-18 F4 · shares: Composed of 35,376 warrant shares exercised by Index Ventures III (Jersey), L.P., 71,862 warrant shares exercised by Index Ventures III (Delaware), L.P., 1,280 warrant shares exercised by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 warrant shares exercised by Index Ventures IV (Jersey), L.P., 4,631 warrant shares exercised by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 warrant shares exercised by Index Ventures V (Jersey), L.P., 313 warrant shares exercised by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 warrant shares exercised by Yucca (Jersey) SLP. F2 · derivative.underlying_shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP. F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey)L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P. F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 19:22 UTC |
De Rubertis FrancescoDirector · 10% owner
|
OtherCommon Stock | 202,634 | $5.77 | $1,169,603.45 |
DisclosureSEC source: 0001140361-16-089639 · doc1.xml · nonDerivative · entry 1 De Rubertis Francesco · CIK 0001601521 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,690,906 F2 · shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP. F3 · balance_after: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey)L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P. F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP. F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act. Read SEC document |
| March 18, 2015 Filed Feb 12, 2016 16:54 UTC |
JOHNSON & JOHNSON10% owner
|
PurchaseCommon Stock | 607,903 | $4.93 | $2,996,961.79 |
DisclosureSEC source: 0000904454-16-000987 · edgar.xml · nonDerivative · entry 1 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc. Disclosed balance after: 3,892,256 F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owed subsidiary of the Reporting Person. Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 22:43 UTC |
JOHNSON & JOHNSON10% owner
|
PurchaseWarrants (right to buy) · Derivative | 607,903 | $0.13 Strike: $5.77 | $75,987.88 |
DisclosureSEC source: 0001144204-15-016825 · v404607_4.xml · derivative · entry 2 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Innovation- JJDC, Inc. Disclosed balance after: 607,903 Underlying: Common Stock · 607,903 shares Expires 2017-03-18 F1 · date: The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015. F1 · derivative.exercise_date: The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015. F3 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation). Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 22:43 UTC |
JOHNSON & JOHNSON10% owner
|
PurchaseCommon Stock | 607,903 | $4.81 | $2,924,013.43 |
DisclosureSEC source: 0001144204-15-016825 · v404607_4.xml · nonDerivative · entry 1 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc. Disclosed balance after: 4,500,159 F1 · date: The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015. F2 · balance_after: Consists of 3,892,256 shares of Common Stock and 607,903 shares of Common Stock underlying immediately exercisable warrants. F3 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.